Treatment with drugs based on tetrahydrocannabinol (THC), substances, contained in cannabis, may help treat inflammatory bowel disease (IBD) and may also help prevent colon cancer. These are the conclusions of researchers from the University of South Carolina.
This research team has long been studying the role of herbal medicines (including cannabis) in the treatment of inflammation. Recent
Cannabinoids act through two receptors in the brain, CB1 and CB2. But if in the first, when THC is activated, psychoactive effects occur, then in the second there is no such effect.
“Our results showed that THC acted through CB2 receptors, which do not induce psychoactive effects and may be useful in preventing IBD and colon cancer,” said study author Mitzi Nagarkatti.
Nowadays, there is an increase in inflammatory bowel diseases around the world, which means that the risk of developing cancer will also increase. Moreover, these diseases are detected in fairly young and middle-aged people.